109 related articles for article (PubMed ID: 6339119)
1. 6 beta-Hydroxyandrostenedione: evidence for a new hypertensinogenic agent.
Sekihara H
Clin Exp Hypertens A; 1983; 5(1):1-9. PubMed ID: 6339119
[TBL] [Abstract][Full Text] [Related]
2. 19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids.
Sekihara H
Endocrinology; 1983 Sep; 113(3):1141-8. PubMed ID: 6347666
[TBL] [Abstract][Full Text] [Related]
3. 19-hydroxyandrostenedione as a new hypertensinogenic agent.
Sekihara H
J Steroid Biochem; 1982 Feb; 16(2):329-31. PubMed ID: 7043093
[TBL] [Abstract][Full Text] [Related]
4. 19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man.
Sekihara H
J Steroid Biochem; 1983 Jul; 19(1A):353-8. PubMed ID: 6310235
[TBL] [Abstract][Full Text] [Related]
5. 19-hydroxyandrostenedione and 6 beta-hydroxyandrostenedione: new steroids regulated by the renin-angiotensin system in man.
Sekihara H
J Steroid Biochem; 1984 Jan; 20(1):383-5. PubMed ID: 6708521
[TBL] [Abstract][Full Text] [Related]
6. 19-Hydroxyandrostenedione amplifies the hypertensive action of mineralocorticoids in rats.
Sekihara H; Yazaki Y; Kojima T
J Endocrinol; 1993 Jul; 138(1):31-40. PubMed ID: 7852890
[TBL] [Abstract][Full Text] [Related]
7. Plasma 19-hydroxyandrostenedione is elevated in patients with high renin essential hypertension.
Sekihara H; Yonemitsu K; Yazaki Y
Clin Endocrinol (Oxf); 1993 Nov; 39(5):557-60. PubMed ID: 8252745
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the hypertensinogenic action of 19-hydroxyandrostenedione by aromatase inhibitor, delta 1-testololactone.
Sekihara H; Yonemitsu K; Takaku F
Endocrinology; 1987 Dec; 121(6):1931-6. PubMed ID: 3678133
[TBL] [Abstract][Full Text] [Related]
9. A reevaluation of the mineralocorticoid and hypertensinogenic potential of 19-hydroxyandrostenedione.
Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 1986 Jun; 118(6):2582-7. PubMed ID: 3698922
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces the release of 19-hydroxyandrostenedione in man.
Sekihara H; Torii R; Osawa Y; Takaku F
J Clin Endocrinol Metab; 1985 Aug; 61(2):291-6. PubMed ID: 2989318
[TBL] [Abstract][Full Text] [Related]
11. Selective 19-hydroxylase inhibition by an aromatase inhibitor, 4-hydroxyandrostenedione.
Griffing GT; Holbrook M; Melby JC; Brodie AH
Clin Physiol Biochem; 1988; 6(3-4):171-8. PubMed ID: 3203487
[TBL] [Abstract][Full Text] [Related]
12. Evidence for age-related change in plasma 19-hydroxyandrostenedione.
Higuchi K; Ogo A; Maki T; Haji M; Takayanagi R; Ohashi M; Nawata H; Kato K; Ibayashi H
Endocrinol Jpn; 1989 Dec; 36(6):881-5. PubMed ID: 2561277
[TBL] [Abstract][Full Text] [Related]
13. 19-Oxoandrost-4-ene-3,17-dione amplifies the action of aldosterone.
Sekihara H; Yazaki Y
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):69-72. PubMed ID: 8338792
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the pressor mechanism of 19-hydroxyandrostenedione].
Honda M; Minato M; Takayama R; Nagashima Y; Watanabe M; Izumi Y; Fukuda N; Soma M; Shiratsuchi T; Watanabe Y
Nihon Naibunpi Gakkai Zasshi; 1989 Jan; 65(1):18-31. PubMed ID: 2524410
[TBL] [Abstract][Full Text] [Related]
15. Low plasma 19-hydroxyandrostenedione levels in patients with aldosterone-producing adenoma.
Morita H; Mune T; Yasuda K; Yamakita N; Miyazaki S; Miura K
Endocr J; 1993 Feb; 40(1):89-97. PubMed ID: 7951501
[TBL] [Abstract][Full Text] [Related]
16. 6 beta-hydroxy-4-androstene-3,17-dione: a potent amplifier of the kaliuretic action of aldosterone.
Sekihara H; Ohsawa N; Kosaka K
J Steroid Biochem; 1981 Apr; 14(4):327-9. PubMed ID: 7230795
[No Abstract] [Full Text] [Related]
17. [A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
Minato M; Honda M; Hatano M
Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):29-41. PubMed ID: 2307256
[TBL] [Abstract][Full Text] [Related]
18. Plasma 19-hydroxy-androstenedione (19-OH-A) in essential hypertension.
Tosti-Croce C; Rinaldi R; Massaria M; Lomurno A; Felicioli T; Sciarra F
Clin Exp Hypertens A; 1992; 14(6):1083-94. PubMed ID: 1330385
[TBL] [Abstract][Full Text] [Related]
19. Alpha-human atrial natriuretic polypeptide inhibits 19-hydroxy-androstenedione secretion by human adrenal cells.
Higuchi K; Nawata H; Kato K; Ibayashi H
Horm Metab Res; 1989 Feb; 21(2):92-5. PubMed ID: 2542147
[TBL] [Abstract][Full Text] [Related]
20. Effects of adrenocorticotropin on adrenal and plasma 11 beta-hydroxyandrostenedione in the guinea pig and determination of its relative androgen potency.
Bélanger B; Fiet J; Bélanger A
Steroids; 1993 Jan; 58(1):29-34. PubMed ID: 8381568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
